Endo Health Solutions Price Target Raised to $48.00 at JPMorgan Chase & Co. (ENDP)
Investment analysts at JPMorgan Chase & Co. increased their target price on shares of Endo Health Solutions (NASDAQ:ENDP) from $45.00 to $48.00 in a note issued to investors on Monday, Stock Ratings Network reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.’s target price would suggest a potential upside of 4.53% from the stock’s previous close.
A number of other firms have also recently commented on ENDP. Analysts at Zacks upgraded shares of Endo Health Solutions from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, October 16th. They now have a $53.00 price target on the stock. Finally, analysts at Susquehanna reiterated a “hold” rating on shares of Endo Health Solutions in a research note to investors on Friday, September 20th. They now have a $42.00 price target on the stock. Six investment analysts have rated the stock with a sell rating, five have given a hold rating and ten have assigned a buy rating to the stock. Endo Health Solutions has an average rating of “Hold” and an average target price of $38.57.
Endo Health Solutions (NASDAQ:ENDP) traded up 0.77% during mid-day trading on Monday, hitting $45.92. 1,026,899 shares of the company’s stock traded hands. Endo Health Solutions has a 1-year low of $25.01 and a 1-year high of $44.73. The stock’s 50-day moving average is $39.62 and its 200-day moving average is $36.33. The company’s market cap is $5.244 billion.
Endo Health Solutions (NASDAQ:ENDP) last released its earnings data on Tuesday, August 6th. The company reported $1.42 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.15 by $0.27. The company had revenue of $766.51 million for the quarter, compared to the consensus estimate of $721.01 million. During the same quarter in the prior year, the company posted $1.27 earnings per share. The company’s quarterly revenue was down 2.4% on a year-over-year basis. On average, analysts predict that Endo Health Solutions will post $4.57 earnings per share for the current fiscal year.
Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.